Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04780477 · ClinicalTrials.gov registry record · NA

Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer

A NA study of Obesity and Colon Cancer, sponsored by Emory University.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04780477 is a NA study of Obesity and Colon Cancer that is active but no longer recruiting, run by Emory University. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04780477, a NA study of Obesity and Colon Cancer, is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study tests whether a high-fiber diet based on legumes, such as dry beans, can lead to sustained reductions in obesity and colon cancer risk in persons at highest risk, namely overweight or obese, post-polypectomy patients.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT High Fiber Diet Featuring Legumes (HLD)
  • DIETARY_SUPPLEMENT Healthy American Diet

Study Locations (1)

Georgia

  • Rollins School of Public Health, Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-06-29
Est. Completion 2025-12
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT04780477

The ClinicalTrials.gov registry entry for NCT04780477 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which High Fiber Diet Featuring Legumes (HLD) is the first listed.

NCT04780477 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04780477 about?

NCT04780477 is a clinical study titled "Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer". This study tests whether a high-fiber diet based on legumes, such as dry beans, can lead to sustained reductions in obesity and colon cancer risk in persons at highest risk, namely overweight or obese, post-polypectomy patients.

What is the current status of trial NCT04780477?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-29. Estimated completion is 2025-12.

What conditions does trial NCT04780477 study?

This clinical trial studies the following conditions: Obesity, Colon Cancer.

What interventions are being tested in trial NCT04780477?

The interventions under investigation include: High Fiber Diet Featuring Legumes (HLD) (DIETARY_SUPPLEMENT), Healthy American Diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04780477?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04780477 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.